- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.09 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.3: 9 residues within 4Å:- Chain A: F.142, K.146, L.149, I.150, P.151, R.175, F.179, K.284
- Chain C: E.114
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:F.142, A:L.149, A:I.150, A:F.179
- Hydrogen bonds: A:T.172, C:E.114
- Salt bridges: A:R.175, A:K.284
PEE.24: 10 residues within 4Å:- Chain B: F.142, K.146, Y.148, L.149, I.150, P.151, R.175, F.179, K.284
- Chain E: E.114
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain E- Hydrophobic interactions: B:F.142, B:L.149, B:I.150, B:F.179
- Hydrogen bonds: B:T.172, E:E.114
- Salt bridges: B:R.175, B:K.284
- 28 x D12: DODECANE(Non-covalent)(Non-functional Binders)
D12.4: 3 residues within 4Å:- Chain A: I.182, I.758
- Ligands: R16.7
Ligand excluded by PLIPD12.5: 4 residues within 4Å:- Chain A: A.808, Y.826
- Chain B: P.851, I.855
Ligand excluded by PLIPD12.6: 5 residues within 4Å:- Chain A: Y.234, L.684, I.752, K.756
- Ligands: 3PE.45
Ligand excluded by PLIPD12.9: 6 residues within 4Å:- Chain A: V.190, F.191, P.195, L.254, I.258, Y.260
Ligand excluded by PLIPD12.10: 4 residues within 4Å:- Chain A: N.360, C.364, R.431
- Ligands: D12.11
Ligand excluded by PLIPD12.11: 4 residues within 4Å:- Chain A: I.434, T.437
- Ligands: D12.10, R16.12
Ligand excluded by PLIPD12.14: 5 residues within 4Å:- Chain A: I.375, I.441, F.445, E.449
- Ligands: R16.13
Ligand excluded by PLIPD12.16: 1 residues within 4Å:- Chain A: I.794
Ligand excluded by PLIPD12.17: 5 residues within 4Å:- Chain A: C.373, S.397, V.398, T.401, F.686
Ligand excluded by PLIPD12.18: 1 residues within 4Å:- Chain A: M.408
Ligand excluded by PLIPD12.19: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD12.20: 2 residues within 4Å:- Chain A: Y.762
- Ligands: PLM.48
Ligand excluded by PLIPD12.25: 3 residues within 4Å:- Chain B: I.182, I.758
- Ligands: R16.28
Ligand excluded by PLIPD12.26: 4 residues within 4Å:- Chain A: P.851, I.855
- Chain B: A.808, Y.826
Ligand excluded by PLIPD12.27: 5 residues within 4Å:- Chain B: Y.234, L.684, I.752, K.756
- Ligands: 3PE.52
Ligand excluded by PLIPD12.30: 5 residues within 4Å:- Chain B: V.190, F.191, P.195, L.254, I.258
Ligand excluded by PLIPD12.31: 5 residues within 4Å:- Chain B: N.360, I.363, C.364, R.431
- Ligands: D12.32
Ligand excluded by PLIPD12.32: 4 residues within 4Å:- Chain B: I.434, T.437
- Ligands: D12.31, R16.33
Ligand excluded by PLIPD12.35: 5 residues within 4Å:- Chain B: I.375, I.441, F.445, E.449
- Ligands: R16.34
Ligand excluded by PLIPD12.37: 1 residues within 4Å:- Chain B: I.794
Ligand excluded by PLIPD12.38: 5 residues within 4Å:- Chain B: C.373, S.397, V.398, T.401, F.686
Ligand excluded by PLIPD12.39: 1 residues within 4Å:- Chain B: M.408
Ligand excluded by PLIPD12.40: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD12.41: 2 residues within 4Å:- Chain B: Y.762
- Ligands: PLM.55
Ligand excluded by PLIPD12.46: 1 residues within 4Å:- Chain D: R.23
Ligand excluded by PLIPD12.47: 6 residues within 4Å:- Chain D: L.36, I.37, V.40, I.41, F.45
- Ligands: PLM.48
Ligand excluded by PLIPD12.53: 1 residues within 4Å:- Chain F: R.23
Ligand excluded by PLIPD12.54: 6 residues within 4Å:- Chain F: L.36, I.37, V.40, I.41, F.45
- Ligands: PLM.55
Ligand excluded by PLIP- 8 x R16: HEXADECANE(Non-covalent)
R16.7: 4 residues within 4Å:- Chain A: P.242, L.748, I.752
- Ligands: D12.4
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:P.242, A:L.748, A:I.752
R16.12: 8 residues within 4Å:- Chain A: M.285, S.782, S.784, N.786, F.787, I.791, I.794
- Ligands: D12.11
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:N.786, A:F.787, A:I.791, A:I.794
R16.13: 4 residues within 4Å:- Chain A: I.371, Y.372, I.434
- Ligands: D12.14
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.371, A:Y.372, A:I.434
R16.15: 6 residues within 4Å:- Chain A: I.694, F.697, R.698, W.701, C.705, F.717
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.697, A:W.701, A:F.717
R16.28: 3 residues within 4Å:- Chain B: P.242, I.752
- Ligands: D12.25
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:P.242, B:I.752
R16.33: 8 residues within 4Å:- Chain B: M.285, S.782, S.784, N.786, F.787, I.791, I.794
- Ligands: D12.32
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:N.786, B:F.787, B:I.791, B:I.794
R16.34: 4 residues within 4Å:- Chain B: I.371, Y.372, I.434
- Ligands: D12.35
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.371, B:Y.372, B:I.434
R16.36: 6 residues within 4Å:- Chain B: I.694, F.697, R.698, W.701, C.705, F.717
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.697, B:W.701, B:F.717
- 2 x CLR: CHOLESTEROL(Non-covalent)
CLR.8: 7 residues within 4Å:- Chain A: F.191, K.259, Y.260, A.261, L.264, M.268, T.272
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.191, A:Y.260, A:Y.260, A:L.264, A:T.272
CLR.29: 8 residues within 4Å:- Chain B: F.191, K.259, Y.260, A.261, L.264, M.268, T.272, E.832
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:F.191, B:Y.260, B:L.264, B:T.272
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
3PE.45: 16 residues within 4Å:- Chain A: K.155, L.684, I.685, L.692, I.759, Y.762, I.763, W.766
- Chain D: L.36, V.40, C.43, C.44, M.46
- Ligands: D12.6, PLM.48, PLM.49
9 PLIP interactions:6 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:L.684, A:I.685, A:L.692, A:I.759, A:W.766, D:L.36, D:L.36
- Salt bridges: A:K.155
- Hydrogen bonds: D:C.44
3PE.52: 16 residues within 4Å:- Chain B: K.155, L.684, I.685, L.692, I.759, Y.762, I.763, W.766
- Chain F: L.36, V.40, C.43, C.44, M.46
- Ligands: D12.27, PLM.55, PLM.56
9 PLIP interactions:6 interactions with chain B, 3 interactions with chain F- Hydrophobic interactions: B:L.684, B:I.685, B:L.692, B:I.759, B:W.766, F:L.36, F:L.36
- Salt bridges: B:K.155
- Hydrogen bonds: F:C.44
- 4 x PLM: PALMITIC ACID(Covalent)
PLM.48: 9 residues within 4Å:- Chain A: I.755, I.758, I.759, Y.762
- Chain D: V.40, C.44
- Ligands: D12.20, 3PE.45, D12.47
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.755, A:I.758, A:I.759, A:I.759, A:Y.762, A:Y.762
PLM.49: 6 residues within 4Å:- Chain A: L.692, L.696
- Chain D: I.39, C.43, I.48
- Ligands: 3PE.45
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:L.692, A:L.696, D:I.39
PLM.55: 9 residues within 4Å:- Chain B: I.755, I.758, I.759, Y.762
- Chain F: V.40, C.44
- Ligands: D12.41, 3PE.52, D12.54
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:I.755, B:I.758, B:I.759, B:I.759, B:Y.762, B:Y.762
PLM.56: 6 residues within 4Å:- Chain B: L.692, L.696
- Chain F: I.39, C.43, I.48
- Ligands: 3PE.52
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain F- Hydrophobic interactions: B:L.692, B:L.696, F:I.39
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jeong, H. et al., Structures of the TMC-1 complex illuminate mechanosensory transduction. Nature (2022)
- Release Date
- 2022-10-19
- Peptides
- Transmembrane channel-like protein 1: AB
CALMyrin (Calcium and Integrin Binding protein) homolog: CE
Transmembrane inner ear expressed protein: DF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CE
ED
DF
F - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.09 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 28 x D12: DODECANE(Non-covalent)(Non-functional Binders)
- 8 x R16: HEXADECANE(Non-covalent)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- 4 x PLM: PALMITIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jeong, H. et al., Structures of the TMC-1 complex illuminate mechanosensory transduction. Nature (2022)
- Release Date
- 2022-10-19
- Peptides
- Transmembrane channel-like protein 1: AB
CALMyrin (Calcium and Integrin Binding protein) homolog: CE
Transmembrane inner ear expressed protein: DF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CE
ED
DF
F - Membrane
-
We predict this structure to be a membrane protein.